SCHEMBL1710646

SCHEMBL1710646

O=Cc1cccc(SCCCc2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.44
MAOA P21397 3/20 0.44
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HIF1A Q16665 1/20 0.41
MCL1 Q07820 1/20 0.40
BCL2A1 Q16548 1/20 0.40
GPR84 Q9NQS5 1/20 0.40
AKR1B10 O60218 1/20 0.39
AKR1B1 P15121 1/20 0.39
ALDH1A1 P00352 3/20 0.39
CA2 P00918 2/20 0.39
MEN1 O00255 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
HDAC1 Q13547 1/20 0.38
CYP2A6 P11509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexane SCHEMBL1724720 0.93 SIGMAR1 (0.40) MAOBMAOACYP1A2CYP3A4CYP2D6
SCHEMBL9373514 0.83 CA2 (0.47) MAOBMAOACYP1A2CYP3A4CYP2D6
SCHEMBL1710689 0.81 MAOA (0.49) MAOBMAOACYP3A4MCL1BCL2A1
SCHEMBL1246050 0.80 CA2 (0.41) MAOBMAOAALDH1A1CA2HDAC1
SCHEMBL1710647 0.80 ALDH1A1 (0.41) MAOBMAOAALDH1A1AR
SCHEMBL1932895 0.78 CYP1A2 (0.62) MAOBMAOACYP1A2CYP3A4CYP2D6
SCHEMBL9480031 0.77 MAOA (0.51) MAOBMAOAGPR84ALDH1A1CYP2A6
SCHEMBL9559961 0.77 MAOA (0.51) MAOBMAOAGPR84ALDH1A1CYP2A6
SCHEMBL11431899 0.77 THRB (0.40) ALDH1A1
SCHEMBL11430039 0.77 THRB (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344451-A2 SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS Acucela, Inc. (US) 2011-07-20 EP disclosed
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-04-15 US disclosed
WO-2010028088-A2 SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ALDH1A2, MPST, CLN6 MAOB 2402/4885MAOA 3658/4885CYP1A2 4705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.